Close Menu
    Latest Posts

    First-time buyer Isa v lifetime Isa – which one should you choose? | Isas

    August 31, 2026

    One Dead, 15 People Unaccounted For After Flash Flooding at the Grand Canyon

    August 31, 2026

    Top analysts suggest these dividend stocks for consistent income

    August 31, 2026
    Facebook X (Twitter) Instagram
    Trending
    • First-time buyer Isa v lifetime Isa – which one should you choose? | Isas
    • One Dead, 15 People Unaccounted For After Flash Flooding at the Grand Canyon
    • Top analysts suggest these dividend stocks for consistent income
    • ADFW 2026 Returns to Abu Dhabi in December under partnership theme
    • Stocks Fall as Hawkish Warsh Boosts Fed Rate Hike Chances
    • Goodyear turnaround continues as cash flow lags
    • Matters Requiring Attention for Violations of Laws and Regulations: Notice of Proposed Rulemaking
    • Appeals court rules against prediction markets, tees up SCOTUS fight
    Facebook X (Twitter) Instagram
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Monday, August 31
    • Home
    • Banking
    • Business
    • Crypto
    • Economy
    • Fintech
    • Investing
    • Markets
    • Stocks
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Home»Economy»Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
    Economy

    Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers

    AdminBy AdminJune 8, 2026No Comments1 Min Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
    Share
    Facebook Twitter Pinterest Email Copy Link


    On this episode of Stock Movers with Alexis Christoforous:

    – Shares of The Campbell’s Company (CPB) edged higher ahead of the US market open after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate.
    – Eli Lilly (LLY) shares gained in the early session following obesity drug presentations at the American Diabetes Association conference. Citi analysts say their conviction on Lilly is firmly intact, given the company’s incretin portfolio is “not built around singular blockbusters.”
    – Shares of Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading as the companies are set to replace Pool Corp. and Campbell’s in S&P 500 before the market open on June 22, S&P Dow Jones Indices says in emailed statement. (Source: Bloomberg)

    Beat Campbell039s drug earnings Eli Lilly Movers obesity Results Stock
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    Admin
    • Website

    Related Posts

    Economy

    A love letter to the A380, the retiring behemoth that takes Qantas travellers back in time | Nick Visser

    August 30, 2026
    Markets

    My mother, 91, has dementia. Every bank says I need her signature to unlock her $100,000 stock certificate. What can I do?

    August 29, 2026
    Stocks

    Berkshire Hathaway Roughly Tripled $10,000 in a Decade. Did It Beat the Market?

    August 29, 2026
    Economy

    Understanding the Distribution of Inflation Expectations

    August 29, 2026
    Investing

    NVIDIA Reports +120% Earnings Growth: Ho-Hum, Just Another Day

    August 27, 2026
    Stocks

    Nvidia stock rises 7% after blockbuster earnings boost AI confidence

    August 27, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    First-time buyer Isa v lifetime Isa – which one should you choose? | Isas

    August 31, 2026

    One Dead, 15 People Unaccounted For After Flash Flooding at the Grand Canyon

    August 31, 2026

    Top analysts suggest these dividend stocks for consistent income

    August 31, 2026

    ADFW 2026 Returns to Abu Dhabi in December under partnership theme

    August 31, 2026
    Latest Posts

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    About Us

    Welcome to MoneyLister.com — your trusted source for reliable insights in the world of finance, investing, and digital assets.

    At MoneyLister, our mission is simple: to make complex financial topics easy to understand and accessible to everyone. Whether you're a beginner exploring cryptocurrency, an investor tracking the stock market, or a professional staying updated on global business trends, we provide clear, informative, and up-to-date content to help you stay ahead.

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    First-time buyer Isa v lifetime Isa – which one should you choose? | Isas

    August 31, 2026

    One Dead, 15 People Unaccounted For After Flash Flooding at the Grand Canyon

    August 31, 2026

    Top analysts suggest these dividend stocks for consistent income

    August 31, 2026
    Recent Posts
    • First-time buyer Isa v lifetime Isa – which one should you choose? | Isas
    • One Dead, 15 People Unaccounted For After Flash Flooding at the Grand Canyon
    • Top analysts suggest these dividend stocks for consistent income
    • ADFW 2026 Returns to Abu Dhabi in December under partnership theme
    • Stocks Fall as Hawkish Warsh Boosts Fed Rate Hike Chances
    © 2026 moneylister. Designed by Pro.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.